Position in NVS
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,687,404
+$42,745 QoQ
Shares Held
10,767
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#473
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GUYASUTA INVESTMENT ADVISORS INC holds $53,362,618 across 9 Drug Manufacturers - General names. NVS ranks #7 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
102,689 | $26,079,925 | |
| 2 | MRK |
Merck & Co., Inc.
|
65,671 | $8,438,723 | |
| 3 | ABBV |
AbbVie Inc.
|
28,312 | $7,124,431 | |
| 4 | LLY |
ELI LILLY & Co
|
2,574 | $3,087,333 | |
| 5 | PFE |
Pfizer Inc
|
113,231 | $2,726,602 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
46,071 | $2,654,611 | |
| 7 | NVS |
Novartis AG
This page
|
10,767 | $1,687,404 | |
| 8 | AMGN |
Amgen Inc
|
3,642 | $1,318,841 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,687,404 | 10,767 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,644,659 | 10,767 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $1,484,446 | 10,767 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,380,760 | 10,767 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $1,302,914 | 10,767 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,165,411 | 10,454 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $1,027,009 | 10,554 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $1,225,538 | 10,655 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,338,521 | 12,573 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $1,225,956 | 12,674 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $1,279,693 | 12,674 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,711,349 | 16,801 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $13,440,101 | 133,189 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $12,657,268 | 137,579 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $12,446,239 | 137,194 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $10,436,781 | 137,308 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $11,505,716 | 136,114 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $11,970,065 | 136,411 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $12,069,635 | 137,986 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $11,390,073 | 139,277 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $12,652,798 | 138,676 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $11,878,984 | 138,968 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $13,470,345 | 142,649 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $12,288,665 | 141,314 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $12,338,871 | 141,274 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $11,099,831 | 134,625 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||